These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 34167531)

  • 1. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
    Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
    BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial.
    Verrastro O; Panunzi S; Castagneto-Gissey L; De Gaetano A; Lembo E; Capristo E; Guidone C; Angelini G; Pennestrì F; Sessa L; Vecchio FM; Riccardi L; Zocco MA; Boskoski I; Casella-Mariolo JR; Marini P; Pompili M; Casella G; Fiori E; Rubino F; Bornstein SR; Raffaelli M; Mingrone G
    Lancet; 2023 May; 401(10390):1786-1797. PubMed ID: 37088093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
    Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
    Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
    von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
    Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.
    Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C
    Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study.
    Toman D; Vavra P; Jelinek P; Ostruszka P; Ihnat P; Foltys A; Pelikan A; Roman J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):195-203. PubMed ID: 33885048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
    Lassailly G; Caiazzo R; Ntandja-Wandji LC; Gnemmi V; Baud G; Verkindt H; Ningarhari M; Louvet A; Leteurtre E; Raverdy V; Dharancy S; Pattou F; Mathurin P
    Gastroenterology; 2020 Oct; 159(4):1290-1301.e5. PubMed ID: 32553765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery.
    Lautenbach A; Wernecke M; Mann O; Wagner J; Wolter S; Stoll F; Aberle J
    Obes Surg; 2023 Feb; 33(2):530-538. PubMed ID: 36508157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
    Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
    Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    Aminian A; Al-Kurd A; Wilson R; Bena J; Fayazzadeh H; Singh T; Albaugh VL; Shariff FU; Rodriguez NA; Jin J; Brethauer SA; Dasarathy S; Alkhouri N; Schauer PR; McCullough AJ; Nissen SE
    JAMA; 2021 Nov; 326(20):2031-2042. PubMed ID: 34762106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bariatric surgery on NAFLD/NASH: a single-centre observational prospective cohort study.
    Theel WB; Boxma-de Klerk BM; Dirksmeier-Harinck F; van Rossum EF; Kanhai DA; Apers JA; van Dalen BM; De Knegt RJ; Neecke B; van der Zwan EM; Grobbee DE; Hankemeier T; Wiebolt J; Castro Cabezas M
    BMJ Open; 2023 Jul; 13(7):e070431. PubMed ID: 37400234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Nonalcoholic Fatty Liver Disease (NAFLD) on Weight Loss After Bariatric Surgery.
    Abu-Rumaileh M; Haddad RA; Yosef M; Esfandiari NH; Kraftson A; Khairi S; Lager C; Bushman J; Khalatbari S; Tincopa M; Varban O; Bozadjieva-Kramer N; Oral EA
    Obes Surg; 2023 Dec; 33(12):3814-3828. PubMed ID: 37940737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How bariatric surgery affects liver volume and fat density in NAFLD patients.
    Luo RB; Suzuki T; Hooker JC; Covarrubias Y; Schlein A; Liu S; Schwimmer JB; Reeder SB; Funk LM; Greenberg JA; Campos GM; Sandler BJ; Horgan S; Sirlin CB; Jacobsen GR
    Surg Endosc; 2018 Apr; 32(4):1675-1682. PubMed ID: 29218660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Shouhed D; Steggerda J; Burch M; Noureddin M
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):797-811. PubMed ID: 28712339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis.
    de Brito E Silva MB; Tustumi F; de Miranda Neto AA; Dantas ACB; Santo MA; Cecconello I
    Obes Surg; 2021 Jun; 31(6):2762-2772. PubMed ID: 33846949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis.
    Poljo A; Kopf S; Sulaj A; Roessler S; Albrecht T; Goeppert B; Bojko S; Müller-Stich BP; Billeter AT
    Surg Obes Relat Dis; 2023 Dec; 19(12):1421-1434. PubMed ID: 37666725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement.
    Nobili V; Vajro P; Dezsofi A; Fischler B; Hadzic N; Jahnel J; Lamireau T; McKiernan P; McLin V; Socha P; Tizzard S; Baumann U
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):550-61. PubMed ID: 25591123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.